| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,366 |
2,260 |
$269K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,815 |
1,797 |
$205K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,905 |
1,894 |
$195K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,831 |
1,776 |
$179K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
943 |
903 |
$61K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
943 |
902 |
$22K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
648 |
628 |
$13K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
312 |
301 |
$11K |
| 87428 |
|
581 |
563 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,716 |
828 |
$10K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,211 |
1,156 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,984 |
1,872 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
13 |
$2K |
| 81025 |
|
425 |
399 |
$445.88 |
| 81003 |
|
574 |
534 |
$149.54 |
| H0033 |
Oral medication administration, direct observation |
28 |
25 |
$0.00 |